Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Insulet Corp (PODD)

Insulet Corp (PODD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

What You Need To Know Ahead of Insulet’s Earnings Release

Insulet Corporation (PODD), headquartered in Acton, Massachusetts, specializes in innovative diabetes management solutions. The company is renowned for its Omnipod Insulin Management System, a tubeless, wearable pump that delivers continuous insulin for up to three days without needles or infusion sets. 

This discreet technology empowers people with type 1 and insulin-dependent type 2 diabetes, offering simplicity and mobility. Insulet operates globally in several countries, with advanced manufacturing driving scalable production and R&D. The company has a market capitalization of $20 billion. 

Fundamentals

See More
  • Market Capitalization, $K 20,046,080
  • Shares Outstanding, K 70,347
  • Annual Sales, $ 2,072 M
  • Annual Income, $ 418,300 K
  • EBIT $ 437 M
  • EBITDA $ 518 M
  • 60-Month Beta 1.40
  • Price/Sales 8.22
  • Price/Cash Flow 64.07
  • Price/Book 14.45

Options Overview Details

View History
  • Implied Volatility 41.40% (-3.24%)
  • Historical Volatility 22.25%
  • IV Percentile 58%
  • IV Rank 49.81%
  • IV High 60.02% on 04/10/25
  • IV Low 22.92% on 08/22/25
  • Expected Move (DTE 29) 23.55 (8.41%)
  • Put/Call Vol Ratio 0.84
  • Today's Volume 57
  • Volume Avg (30-Day) 245
  • Put/Call OI Ratio 1.14
  • Today's Open Interest 6,192
  • Open Int (30-Day) 8,470
  • Expected Range 256.46 to 303.55

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 26 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.48
  • Number of Estimates 10
  • High Estimate 1.86
  • Low Estimate 1.32
  • Prior Year 1.15
  • Growth Rate Est. (year over year) +28.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
275.10 +1.78%
on 01/14/26
299.80 -6.60%
on 01/07/26
-11.57 (-3.97%)
since 12/22/25
3-Month
275.10 +1.78%
on 01/14/26
354.88 -21.10%
on 11/20/25
-49.22 (-14.95%)
since 10/22/25
52-Week
230.05 +21.71%
on 03/10/25
354.88 -21.10%
on 11/20/25
+1.11 (+0.40%)
since 01/22/25

Most Recent Stories

More News
What You Need To Know Ahead of Insulet’s Earnings Release

Here’s what analysts are expecting from the underperforming stock Insulet prior to its Q4 earnings.

XLV : 158.29 (+0.02%)
$SPX : 6,913.35 (+0.55%)
PODD : 280.00 (-1.74%)
1 Safe-and-Steady Stock with Impressive Fundamentals and 2 We Find Risky

1 Safe-and-Steady Stock with Impressive Fundamentals and 2 We Find Risky

BOKF : 135.58 (-0.37%)
PODD : 280.00 (-1.74%)
WMT : 117.83 (-1.28%)
Stocks Recover as Data Storage Companies and Chip Makers Rally

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.08%. March E-mini S&P...

AMAT : 318.79 (-1.98%)
B : 49.24 (+0.35%)
AVGO : 325.49 (-1.01%)
C : 115.66 (+1.58%)
HL : 31.29 (+8.34%)
HSIC : 78.47 (-0.60%)
CDE : 25.77 (+12.48%)
JPM : 303.63 (+0.53%)
AKAM : 97.03 (+3.53%)
ANIP : 85.39 (-0.15%)
$IUXX : 25,518.35 (+0.76%)
UNH : 354.47 (+1.93%)
Insulet to Announce Fourth Quarter and Full Year 2025 Financial Results on February 18, 2026 

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced...

PODD : 280.00 (-1.74%)
3 Healthcare Stocks with Exciting Potential

3 Healthcare Stocks with Exciting Potential

COR : 352.47 (+0.20%)
PODD : 280.00 (-1.74%)
ABBV : 218.11 (+0.91%)
Insulet Redefines Diabetes at CES with "Liveable Technology" — A New Frontier in Human-Centered Connected Health

The Company will host a Digital Health Track panel discussion exploring how human-first design and intelligent automation are transforming chronic care into everyday freedom ...

PODD : 280.00 (-1.74%)
Biotech’s New Edge: 5 Companies Mastering "How" We Dose

ISSUED ON BEHALF OF DOSEOLOGY SCIENCES INC. VANCOUVER – Baystreet.ca News Commentary – Pharmaceutical markets are witnessing drug delivery devices surge toward $862.16 billion by 2034 as industry...

MOOD.CN : 0.7600 (-2.56%)
WST : 247.78 (-2.89%)
PODD : 280.00 (-1.74%)
DOSEF : 0.6000 (+18.55%)
LPCN : 10.44 (+7.74%)
DARE : 1.9700 (+1.55%)
2 Mid-Cap Stocks to Own for Decades and 1 That Underwhelm

2 Mid-Cap Stocks to Own for Decades and 1 That Underwhelm

CHRW : 177.90 (-0.83%)
SMCI : 32.45 (+0.65%)
PODD : 280.00 (-1.74%)
Is Insulet Stock Underperforming the Nasdaq?

Although Insulet has underperformed the Nasdaq recently, analysts remain highly optimistic about the stock’s prospects.

$NASX : 23,436.02 (+0.91%)
PODD : 280.00 (-1.74%)
MDT : 101.34 (+1.05%)
Insulet to Participate in 44th Annual J.P. Morgan Healthcare Conference

Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the 44 ...

PODD : 280.00 (-1.74%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System...

See More

Key Turning Points

3rd Resistance Point 298.86
2nd Resistance Point 293.13
1st Resistance Point 286.57
Last Price 280.00
1st Support Level 274.28
2nd Support Level 268.55
3rd Support Level 261.99

See More

52-Week High 354.88
Fibonacci 61.8% 307.19
Fibonacci 50% 292.46
Last Price 280.00
Fibonacci 38.2% 277.74
52-Week Low 230.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar